StonvexLoading…
StonvexStonvexStonvexCore line items from XERS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $83.13M | $291.85M | $206.04M | $131.66M |
Operating Income | $7.92M | $24.90M | $8.12M | $1.39M |
Net Income | $2.23M | $554.00K | $-10.53M | $-1.93M |
EPS (Diluted) | $0.01 | $0.00 | $-0.07 | $-0.07 |
Total Assets | $392.01M | $383.53M | $370.19M | $334.69M |
Total Liabilities | $379.00M | $369.84M | $371.05M | $353.99M |
Cash & Equivalents | $111.75M | $111.04M | $91.60M | $59.28M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 172.56M | 166.22M | 165.53M | 161.22M |